Referrals to Infusion Care
For the Puget Sound, Spokane and Yakima regions
Health care providers can find order sets on this page to refer patients to home infusion or to a MultiCare ambulatory infusion center.
Please note: Oncology infusion services must be coordinated through a MultiCare Cancer Institute location. Pediatric infusion services should be coordinated through Mary Bridge Children’s Hospital & Health Network.
How to refer to ambulatory and home infusion services
To refer your patient:
- Select the appropriate ambulatory infusion or home infusion order below
- Thoroughly complete the order
- Fax ambulatory infusion orders to 833-380-8800
- Fax home infusion orders to 253-864-2785
- Fax Spokane infusion orders to 509-755-5845 (please note: Spokane does not offer home infusion)
Upon receipt of the referral, infusion center staff will:
- Obtain prior authorization for services, if necessary
- Contact the patient to schedule an appointment, once authorization is obtained
- Provide the patient with cost estimate for services, upon request

Contact us
If you have questions about an ambulatory infusion patient referral, please call the infusion center where your patient is seen.
Ambulatory infusion orders
- Abatacept (Orencia)
- Agalsidase beta (Fabrazyme)
- Antibiotic infusion orders (Adults)
- Belimumab (Benlysta)
- Benralizumab (Fasenra)
- Blood products (Adults)
- Burosumab-twza (Crysvita)
- Canakinumab (Ilaris)
- Certolizumab (Cimzia)
- Darbepoetin and Epoetin
- Eculizumab (Soliris)
- Efgartigimod alfa (Vyvgart)
- Emicizumab kxwh (Hemlibra)
- Enoxaparin (Lovenox) Bridge Therapy
- Golimumab (Simponi Aria)
- Guselkumab (Tremfya)
- Immune globulin (IVIG)
- Inclisiran (Leqvio)
- Infliximab (Remicade) or other biosimilar
- Infusion center orders
- Iron
- Lecanemab (Leqembi)
- Mirikizumab-mrkz (Omvoh)
- Mepolizumab (Nucala)
- Methotrexate for ectopic pregnancy
- Multiple sclerosis
- Ocrelizumab (Ocrevus)
- Omalizumab (Xolair)
- Osteoporosis treatments
- Phlebotomy
- Pegloticase (Krystexxa)
- Rabies vaccine
- Ravulizumab-cwvz (Ultomiris)
- Risankizumab (Skyrizi)
- Rituximab (Rituxan) or biosimilar
- Rozanolixizumab noli (Rystiggo)
- Secukinumab (Cosentyx)
- Spesolimab-sbzo (Spevigo)
- Teprotumumab (Tepezza)
- Tezepelumab (Tezspire)
- Tocilizumab (Actemra) or other biosimilar
- Ublituximab (Briumvi)
- Ustekinumab (Stelara)
- Vedolizumab (Entyvio)
- Vutrisiran (Amvuttra)
Home infusion orders
- Abatacept (Orencia)
- Agalsidase Beta (Fabrazyme)
- Anifrolumab-fnia (Saphnelo)
- Belimumab (Benlysta)
- Benralizumab (Fasenra)
- Certolizumab (Cimzia)
- Denosumab (Prolia)
- Eculizumab (Soliris)
- Efgartigimod alfa and hyaluronidase (Vyvgart Hytrulo)
- Efgartimod alfa-fcab (Vyvgart)
- Eptinezumab-jjmr (Vyepti)
- General Infusion Orders
- Golimumab (Simponi Aria)
- Guselkumab (Tremfya)
- Immune Globulin (IVIG)
- Inclisiran (Leqvio)
- Infliximab or biosimilar
- Ipilimumab (Yervoy)
- Iron Infusion
- IV Fluids
- Mepolizumab (Nucala)
- Methylprednisolone
- Natalizumab (Tysabri)
- Nivolumab (Opdivo)
- Ocrelizumab (Ocrevus)
- Omalizumab (Xolair)
- One-Time Visit
- Pembrolizumab (Keytruda)
- Ravulizumab-cwvz (Ultomiris)
- Risankizumab (Skyrizi)
- Rituximab or biosimilar
- Romosozumab-aqqg (Evenity)
- Tezepelumab (Tezspire)
- Tocilizumab or biosimilar
- Ubilituximab (Briumvi)
- Vedolizumab (Entyvio)
- Zoledronic Acid (Reclast)
Please note: the MultiCare Cancer Institute – Deaconess Hospital and MultiCare Cancer Institute – North Spokane locations do not offer home infusion.